Active Diabetes Studies

We are constantly seeking participants for a number of studies. Please apply to any studies for which you may qualify, or call us at (417) 883-7889 for more information!

If You Suffer from Diabetes, Clinvest Is Here to Help

With nearly 29 million people affected in the United States alone, diabetes is a condition that deserves attention. Severe long-term side effects like heart attacks, strokes, kidney disease, or blindness, all are associated with diabetes. Make a difference in this ongoing battle by participating in a research study.

Clinvest understands how challenging and frustrating diabetic conditions can be. We have a strong commitment to further treatment and research in diabetes studies. We partner with pharmaceutical companies in an effort to discover solutions for life-limiting conditions and look forward to the new horizons in health and well-being.

    Diabetes Research Study

    I8F-MC-GPGL

    Clinvest is seeking volunteers with Type 2 Diabetes. This phase 3 study is evaluating the safety and efficacy of investigational study drug versus Semaglutide as a once weekly add-on injection therapy to metformin in patients with Type 2 Diabetes. Eligible participants need to have an HbA1c between 7%-10.5% and be on a stable dose of at least 1500 mg of metformin per day. The study will have 12 office visits over approximately 47 weeks. Your first appointment would last approximately 2 hours with follow-up visits lasting around 1 hour. Study medication, and diabetes testing supplies would be provided, as well as all study-related procedures, at no cost to you (including basic study-related physical exams, bloodwork, HbA1c, ECG’s, and urine drug/pregnancy tests). Compensation will be provided for your time and travel.

    Duration: 47 Weeks

    Number: 12

Want to find out when new studies are available?

Fill out the form!